Cargando…

Primary lateral sclerosis: consensus diagnostic criteria

Primary lateral sclerosis (PLS) is a neurodegenerative disorder of the adult motor system. Characterised by a slowly progressive upper motor neuron syndrome, the diagnosis is clinical, after exclusion of structural, neurodegenerative and metabolic mimics. Differentiation of PLS from upper motor neur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Turner, Martin R, Barohn, Richard J, Corcia, Philippe, Fink, John K, Harms, Matthew B, Kiernan, Matthew C, Ravits, John, Silani, Vincenzo, Simmons, Zachary, Statland, Jeffrey, van den Berg, Leonard H, Mitsumoto, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Neurodegeneration
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147236/ https://www.ncbi.nlm.nih.gov/pubmed/32029539 http://dx.doi.org/10.1136/jnnp-2019-322541

Ejemplares similares

Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights
por: Vucic, Steve, et al.
Publicado: (2013)

Validation of the new consensus criteria for the diagnosis of corticobasal degeneration
por: Alexander, S K, et al.
Publicado: (2014)

UNC13A in amyotrophic lateral sclerosis: from genetic association to therapeutic target
por: Willemse, Sean W, et al.
Publicado: (2023)

The expanding syndrome of amyotrophic lateral sclerosis: a clinical and molecular odyssey
por: Turner, Martin R, et al.
Publicado: (2015)

Value of systematic genetic screening of patients with amyotrophic lateral sclerosis
por: Shepheard, Stephanie R, et al.
Publicado: (2021)

Cerebrovascular injury as a risk factor for amyotrophic lateral sclerosis
por: Turner, Martin R, et al.
Publicado: (2016)

Cognition and behaviour in frontotemporal dementia with and without amyotrophic lateral sclerosis
por: Saxon, Jennifer A, et al.
Publicado: (2020)

Retrotransposons in the development and progression of amyotrophic lateral sclerosis
por: Savage, Abigail L, et al.
Publicado: (2019)

Sensitivity of brain MRI and neurological examination for detection of upper motor neurone degeneration in amyotrophic lateral sclerosis
por: Nitert, Abram D, et al.
Publicado: (2022)

Increased functional connectivity common to symptomatic amyotrophic lateral sclerosis and those at genetic risk
por: Menke, Ricarda A L, et al.
Publicado: (2016)

Higher blood high density lipoprotein and apolipoprotein A1 levels are associated with reduced risk of developing amyotrophic lateral sclerosis
por: Thompson, Alexander G, et al.
Publicado: (2022)

Genetic screening in sporadic ALS and FTD
por: Turner, Martin R, et al.
Publicado: (2017)

Measuring network disruption in neurodegenerative diseases: New approaches using signal analysis
por: McMackin, Roisin, et al.
Publicado: (2019)

TDP-43 proteinopathies: a new wave of neurodegenerative diseases
por: de Boer, Eva Maria Johanna, et al.
Publicado: (2021)

Can regional spreading of amyotrophic lateral sclerosis motor symptoms be explained by prion-like propagation?
por: Kanouchi, Tadashi, et al.
Publicado: (2012)

Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker
por: Kassubek, Jan, et al.
Publicado: (2018)

Neuronal network disintegration: common pathways linking neurodegenerative diseases
por: Ahmed, Rebekah M, et al.
Publicado: (2016)

Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study
por: Lu, Ching-Hua, et al.
Publicado: (2015)

Younger age of onset in familial amyotrophic lateral sclerosis is a result of pathogenic gene variants, rather than ascertainment bias
por: Mehta, Puja R, et al.
Publicado: (2019)

Development of a sensitive trial-ready poly(GP) CSF biomarker assay for C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis
por: Wilson, Katherine M, et al.
Publicado: (2022)

Plasma microRNA signature in presymptomatic and symptomatic subjects with C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis
por: Kmetzsch, Virgilio, et al.
Publicado: (2021)

Widespread structural brain involvement in ALS is not limited to the C9orf72 repeat expansion
por: Westeneng, Henk-Jan, et al.
Publicado: (2016)

Hypermetabolism in ALS is associated with greater functional decline and shorter survival
por: Steyn, Frederik J, et al.
Publicado: (2018)

Serum neuronal exosomes predict and differentiate Parkinson’s disease from atypical parkinsonism
por: Jiang, Cheng, et al.
Publicado: (2020)

Relative preservation of triceps over biceps strength in upper limb-onset ALS: the ‘split elbow’
por: Khalaf, Roaya, et al.
Publicado: (2019)

Examining the language and behavioural profile in FTD and ALS-FTD
por: Saxon, Jennifer A, et al.
Publicado: (2017)

Imaging and CSF analyses effectively distinguish CJD from its mimics
por: Rudge, Peter, et al.
Publicado: (2018)

Predicting loss of independence and mortality in frontotemporal lobar degeneration syndromes
por: Murley, Alexander G, et al.
Publicado: (2021)

Longitudinal thalamic white and grey matter changes associated with visual hallucinations in Parkinson’s disease
por: Zarkali, Angeliki, et al.
Publicado: (2022)

Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-β peptide and τ levels: target engagement, tolerability and pharmacokinetics in humans
por: Maccecchini, Maria L, et al.
Publicado: (2012)

Neurofilament light chain and tau concentrations are markedly increased in the serum of patients with sporadic Creutzfeldt-Jakob disease, and tau correlates with rate of disease progression
por: Thompson, Andrew Geoffrey Bourne, et al.
Publicado: (2018)

Unravelling the clinical spectrum and the role of repeat length in C9ORF72 repeat expansions
por: van der Ende, Emma L., et al.
Publicado: (2021)

Platelet abnormalities in Huntington’s disease
por: Denis, Hélèna L, et al.
Publicado: (2019)

Quantitative EEG parameters correlate with the progression of human prion diseases
por: Franko, Edit, et al.
Publicado: (2016)

Neurodegenerative disease risk among former international rugby union players
por: Russell, Emma R, et al.
Publicado: (2022)

Patterns of atrophy in pathologically confirmed dementias: a voxelwise analysis
por: Harper, Lorna, et al.
Publicado: (2017)

Oligogenic genetic variation of neurodegenerative disease genes in 980 postmortem human brains
por: Keogh, Michael J, et al.
Publicado: (2018)

Development of novel clinical examination scales for the measurement of disease severity in Creutzfeldt-Jakob disease
por: Nihat, Akin, et al.
Publicado: (2022)

Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management
por: O'Brien, John, et al.
Publicado: (2020)

Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer’s disease, frontotemporal dementia and progressive supranuclear palsy
por: Chouliaras, Leonidas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_upd2ln9v5g1g7mm45sc9ebtvi0